The role of galectins in colorectal cancer progression
暂无分享,去创建一个
[1] R. Lotan,et al. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. , 1991, Cancer research.
[2] T. Yoshii,et al. Endogenous Galectin-3 Determines the Routing of CD95 Apoptotic Signaling Pathways , 2004, Cancer Research.
[3] E. P. Moiseeva,et al. Galectin 1 Modulates Attachment, Spreading and Migration of Cultured Vascular Smooth Muscle Cells via Interactions with Cellular Receptors and Components ofExtracellu lar Matrix , 1999, Journal of Vascular Research.
[4] Robert Kiss,et al. Prognostic Values of Galectin-3 and the Macrophage Migration Inhibitory Factor (MIF) in Human Colorectal Cancers , 2003, Modern Pathology.
[5] N. Tinari,et al. Concentrations of galectin-3 in the sera of normal controls and cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] G. Rabinovich,et al. Functions of cell surface galectin-glycoprotein lattices. , 2007, Current opinion in structural biology.
[7] S. Barondes,et al. Galectins. Structure and function of a large family of animal lectins. , 1994, The Journal of biological chemistry.
[8] L. Baum,et al. Apoptosis of T cells mediated by galectin-1 , 1995, Nature.
[9] P. Rao,et al. Galectin‐4 functions as a tumor suppressor of human colorectal cancer , 2011, International journal of cancer.
[10] M. Wu,et al. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells , 2008, Oncogene.
[11] A. Hoeflich,et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures , 2001, Journal of Cancer Research and Clinical Oncology.
[12] T. Yoshii,et al. Galectin-3 Phosphorylation Is Required for Its Anti-apoptotic Function and Cell Cycle Arrest* , 2002, The Journal of Biological Chemistry.
[13] P. Matarrese,et al. Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions. , 2004, Glycobiology.
[14] K. Pienta,et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. , 2000, The American journal of pathology.
[15] H. Inohara,et al. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. , 1996, Cancer research.
[16] H. Inohara,et al. Bh1 (nwgr) Domain of Bcl-2 Family Galectin-3: a Novel Antiapoptotic Molecule with a Functional Updated Version Citing Articles E-mail Alerts Galectin-3: a Novel Antiapoptotic Molecule with a Functional Bh1 (nwgr) Domain of Bcl-2 Family' , 2022 .
[17] I. Ishizuka. Chemistry and functional distribution of sulfoglycolipids. , 1997, Progress in lipid research.
[18] R. Bresalier,et al. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. , 2004, Gastroenterology.
[19] R. Kiss,et al. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting , 2003, Cancer.
[20] Xiaodong Wang,et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death , 2004, Cell Death and Differentiation.
[21] Lu-Gang Yu. Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis. , 2010, World journal of gastrointestinal oncology.
[22] K. Kayser,et al. Galectins-1 and -3 and their ligands in tumor biology , 1999, Journal of Cancer Research and Clinical Oncology.
[23] R. Lotan,et al. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. , 1995, Cancer research.
[24] J. Hirabayashi,et al. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. , 2000, Glycobiology.
[25] E. Campo,et al. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. , 1997, Gastroenterology.
[26] J. Dennis,et al. Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor Cells , 2006, Molecular and Cellular Biology.
[27] M. F. Troncoso,et al. Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem‐repeat” lectin galectin‐8 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] J. Hirabayashi,et al. Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion* , 2007, Journal of Biological Chemistry.
[29] M. Huflejt,et al. Galectin-4 in normal tissues and cancer , 2003, Glycoconjugate Journal.
[30] L. Baum,et al. Presentation of Galectin-1 by Extracellular Matrix Triggers T Cell Death* , 2004, Journal of Biological Chemistry.
[31] Novel carbohydrate specificity of the 16-kDa galectin from Caenorhabditis elegans: binding to blood group precursor oligosaccharides (type 1, type 2, Talpha, and Tbeta) and gangliosides. , 2002, Glycobiology.
[32] Michael R. Green,et al. Localization of pre-mRNA splicing in mammalian nuclei , 1994, Nature.
[33] R. Lotan,et al. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. , 1994, Cancer research.
[34] K. Yamashita,et al. High-affinity binding of recombinant human galectin-4 to SO3–→3Galβ1→3GalNAc pyranoside , 2002 .
[35] C. Decaestecker,et al. The galectin family and digestive disease , 2008, The Journal of pathology.
[36] L. Earl,et al. N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death* , 2009, The Journal of Biological Chemistry.
[37] L. Baum,et al. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. , 2007, Cancer research.
[38] H. Kwon,et al. Aminopeptidase N/CD13 induces angiogenesis through interaction with a pro-angiogenic protein, galectin-3. , 2007, Biochemical and biophysical research communications.
[39] Y. Takenaka,et al. Galectin-3 and metastasis , 2004, Glycoconjugate Journal.
[40] Ruud P. M. Dings,et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy , 2006, Proceedings of the National Academy of Sciences.
[41] C. Oshima,et al. Immunoexpression of Galectin-3 in Colorectal Cancer and its Relationship with Survival , 2011, Journal of gastrointestinal cancer.
[42] J. Dennis,et al. Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.
[43] R. Finley,et al. Galectin-3 Translocates to the Perinuclear Membranes and Inhibits Cytochrome c Release from the Mitochondria , 2002, The Journal of Biological Chemistry.
[44] R. Kiss,et al. Upregulation of galectins‐1 and ‐3 in human colon cancer and their role in regulating cell migration , 2003, International journal of cancer.
[45] K. Yamashita,et al. High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1-->3GalNAc pyranoside. , 2002, Glycobiology.
[46] S. Deutscher,et al. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. , 2004, Carcinogenesis.
[47] M. Fukuda,et al. Galectin-1 Binds Different CD43 Glycoforms to Cluster CD43 and Regulate T Cell Death1 , 2006, The Journal of Immunology.
[48] R. Kiss,et al. Molecular and Cellular Pathobiology Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity , 2022 .
[49] J. Price,et al. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. , 1996, Cancer research.
[50] R. Kiss,et al. Anti-galectin compounds as potential anti-cancer drugs. , 2006, Current medicinal chemistry.
[51] S. Fakan,et al. Localization and characterization of newly synthesized nuclear RNA in isolate rat hepatocytes. , 1976, Experimental Cell Research.
[52] C. Fred Brewer. Binding and cross-linking properties of galectins. , 2002, Biochimica et biophysica acta.
[53] Vladislav V Glinsky,et al. Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. , 2009, Carbohydrate research.
[54] S. Bouraoui,et al. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients). , 2010, Bulletin du cancer.
[55] A. Mercurio,et al. Carbohydrate-binding protein 35 is the major cell-surface laminin-binding protein in colon carcinoma. , 1991, Archives of surgery.
[56] Y. Kloog,et al. Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity* , 2004, Journal of Biological Chemistry.
[57] S. Barondes,et al. Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides. , 1986, The Journal of biological chemistry.
[58] R. Bresalier,et al. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. , 1998, Gastroenterology.
[59] J. Rhodes,et al. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. , 2009, Cancer research.
[60] K. Yamashita,et al. Galectin-4 Binds to Sulfated Glycosphingolipids and Carcinoembryonic Antigen in Patches on the Cell Surface of Human Colon Adenocarcinoma Cells* , 2005, Journal of Biological Chemistry.
[61] S. Barondes,et al. Strikingly Different Localization of Galectin-3 and Galectin-4 in Human Colon Adenocarcinoma T84 Cells , 1997, The Journal of Biological Chemistry.
[62] R. Bresalier,et al. Phosphorylation of the β-Galactoside-binding Protein Galectin-3 Modulates Binding to Its Ligands* , 2000, The Journal of Biological Chemistry.
[63] H. Nakada,et al. Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells. , 2003, Journal of biochemistry.
[64] M. Kurimoto,et al. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. , 1999, International journal of oncology.
[65] C. Colnot,et al. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin‐3‐null mutant mice , 1998, Immunology.
[66] N. Goldstein,et al. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[67] S. Fakan,et al. Localization and characterization of newly synthesized nuclear RNA in isolated rat hepatocytes , 1976 .
[68] R. Alon,et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. , 2000, Journal of cell science.
[69] R. Bresalier,et al. Expression of an endogenous galactose‐binding lectin correlates with neoplastic progression in the colon , 1995 .
[70] P. Fisher,et al. Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human Galectin-8 related gene , 2000, Oncogene.
[71] N. Samani,et al. Galectin 1 inhibits incorporation of vitronectin and chondroitin sulfate B into the extracellular matrix of human vascular smooth muscle cells. , 2003, Biochimica et biophysica acta.
[72] V. Castronovo,et al. Galectin-3 and cancer (Review). , 2004, International journal of oncology.
[73] G. Rabinovich,et al. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2 , 2000, Cell Death and Differentiation.
[74] I Salmon,et al. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor , 2002, Gut.
[75] J. Rhodes,et al. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis , 2010, Molecular Cancer.
[76] Fu-Tong Liu,et al. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response , 2009, The Journal of experimental medicine.
[77] P. Stewart,et al. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. , 1999, Journal of immunology.
[78] K. Roszkowski,et al. Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and d-galactose , 2004, Journal of Cancer Research and Clinical Oncology.
[79] P. Matarrese,et al. Galectin-1 Sensitizes Resting Human T Lymphocytes to Fas (CD95)-mediated Cell Death via Mitochondrial Hyperpolarization, Budding, and Fission* , 2005, Journal of Biological Chemistry.
[80] R. Kiss,et al. Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. , 2010, Immunology letters.
[81] J. L. Wang,et al. Intranuclear distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron microscopy. , 1995, Experimental cell research.
[82] R. Liskamp,et al. Rigidified multivalent lactose molecules and their interactions with mammalian galectins: a route to selective inhibitors. , 2003, Organic & biomolecular chemistry.
[83] Y. Maehara,et al. Galectin-3 expression is a potent prognostic marker in colorectal cancer. , 2005, Anticancer research.
[84] Y. Honjo,et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. , 2002, Journal of the National Cancer Institute.